We are live on
!
Find out more
IAP
Indie Asset Partners Portfolio holdings
AUM
$87.8M
1-Year Est. Return
27.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.95%
1 Year Est. Return
+27.76%
3 Year Est. Return
+120.76%
5 Year Est. Return
+150.7%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$35.5M
(+40%)
Cap. Flow
+$28.5M
Cap. Flow
% of AUM
23.09%
Top 10 Holdings %
Top 10 Hldgs %
55.69%
Holding
132
New
13
Increased
29
Reduced
64
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$29.6M |
| 2 |
Vanguard Energy ETF
VDE
|
+$637K |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$557K |
| 4 |
iShares MSCI Global Metals & Mining Producers ETF
PICK
|
+$371K |
| 5 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$346K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackRock Municipal 2030 Target Term Trust
BTT
|
+$1.08M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$834K |
| 3 |
Enterprise Products Partners
EPD
|
+$416K |
| 4 |
Commault Systems
CVLT
|
+$322K |
| 5 |
Apple
AAPL
|
+$265K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.79% |
| 2 | Technology | 12.17% |
| 3 | Consumer Discretionary | 5.12% |
| 4 | Communication Services | 3.46% |
| 5 | Financials | 3.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$26.1B
| $29.2M | 23.64% |
711,623
+695,600
| +4,341% | +$29.6M |
|
2
Eli Lilly
LLY
$1.07T
| $15.5M | 12.6% |
67,709
-270
| -0.4% | -$54.2K |
|
|
3
Apple
AAPL
$4.89T
| $5.78M | 4.69% |
42,199
-2,048
| -5% | -$265K |
|
4
Amazon
AMZN
$2.5T
| $3.64M | 2.95% |
21,140
-1,160
| -5% | -$193K |
|
5
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
| $3.43M | 2.78% |
40,066
-2,100
| -5% | -$179K |
|
|
BLCN
6
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
| $2.83M | 2.29% |
59,525
-400
| -0.7% | -$19.1K |
|
7
Schwab US Dividend Equity ETF
SCHD
$102B
| $2.31M | 1.87% |
91,755
-423
| -0.5% | -$10.7K |
|
8
ADC Therapeutics
ADCT
$146M
| $2.23M | 1.81% |
91,641
-475
| -0.5% | -$11K |
|
9
Meta Platforms (Facebook)
META
$1.51T
| $2.03M | 1.64% |
5,829
+20
| +0.3% | +$6.42K |
|
10
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
| $1.74M | 1.41% |
95,376
-6,600
| -6% | -$114K |
|
11
Microsoft
MSFT
$2.84T
| $1.59M | 1.29% |
5,865
-137
| -2% | -$34.8K |
|
12
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
| $1.36M | 1.1% |
41,325
+6,950
| +20% | +$225K |
|
13
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $1.15M | 0.93% |
21,850
+600
| +3% | +$31.3K |
|
|
SLY
14
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $1.12M | 0.91% |
11,459
-485
| -4% | -$46.8K |
|
|
15
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $1.11M | 0.9% |
10,885
-8,180
| -43% | -$834K |
|
16
American Tower
AMT
$77.7B
| $1M | 0.81% |
3,711
-200
| -5% | -$51K |
|
17
Visa
V
$677B
| $989K | 0.8% |
4,231
-413
| -9% | -$94.4K |
|
18
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $959K | 0.78% |
2,241
+20
| +0.9% | +$8.35K |
|
19
First Trust Capital Strength ETF
FTCS
$7.88B
| $938K | 0.76% |
12,422
+1,335
| +12% | +$99.3K |
|
20
Schwab International Equity ETF
SCHF
$65.6B
| $881K | 0.71% |
44,670
+2
| +0% | +$40 |
|
21
Schwab US Broad Market ETF
SCHB
$42.8B
| $880K | 0.71% |
50,658
-1,680
| -3% | -$28.4K |
|
22
Asana
ASAN
$1.58B
| $862K | 0.7% |
13,900
-2,250
| -14% | -$86.8K |
|
23
Sherwin-Williams
SHW
$78.3B
| $806K | 0.65% |
2,958
| – | – |
|
|
24
Commault Systems
CVLT
$5.89B
| $793K | 0.64% |
10,150
-4,425
| -30% | -$322K |
|
25
Pfizer
PFE
$140B
| $792K | 0.64% |
20,226
-1,700
| -8% | -$66.1K |
|
Similar funds
DG
XXIP
CVM
BCP
PM
PBCM
S2L
IC
Indie Asset Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Indie Asset Partners held 132 positions worth $123M, up 40% from $87.9M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Indie Asset Partners deployed $28.5M of net new capital in Q2 2021, opening 13 new positions and adding to 29 existing holdings. Its largest new stake was Vanguard Energy ETF: 8,785 shares worth $667K.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $834K trimmed.
- Indie Asset Partners's largest Q2 2021 buy was Vanguard Energy ETF: 8,785 shares worth $667K.
- Indie Asset Partners added most to Royalty Pharma in Q2 2021, an estimated $29.6M increase.
- Indie Asset Partners's biggest Q2 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $834K.
- Indie Asset Partners fully exited BlackRock Municipal 2030 Target Term Trust in Q2 2021, selling an estimated $1.08M.
- Indie Asset Partners's ten largest holdings make up 56% of its $123M portfolio in Q2 2021.
- Indie Asset Partners opened 13 new positions and closed 4 in Q2 2021.
- Indie Asset Partners's portfolio value rose 40% quarter-over-quarter to $123M.
Based on Indie Asset Partners's 13F filing for Q2 2021, filed 11 Aug 2021.